Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …

Alzheimer's disease (AD) is a neurodegenerative disorder accounting for over 50% of all
dementia patients and representing a leading cause of death worldwide for the global …

Polyunsaturated fatty acids (PUFAs) are essential components in eukaryotic cell membrane.
They take part in the regulation of cell signalling pathways and act as precursors in …

The development of early non-invasive diagnosis methods and identification of novel
biomarkers are necessary for managing Alzheimer's disease (AD) and facilitating effective …

Global incidence of neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD)
and Parkinson's disease (PD) is rapidly increasing, but the diagnosis of these diseases at …

The abundance of docosahexaenoic acid (DHA) in brain membrane phospholipids has
stimulated studies to explore its role in neurological functions. Upon released from …

Oxylipins are bioactive lipid mediators that participate in a wide range of processes, from
blood flow to inflammation. In recent years, their exhaustive characterization as potential …

Alzheimer's disease (AD) represents a global health challenge, with an estimated 55 million
people suffering from the non-curable disease across the world. While amyloid-plaques and …

Alzheimer's disease (ad) adversely affects the health, quality of life and independence of
patients. There is a critical need to identify novel blood gene biomarkers for ad risk …

Introduction Prospective studies on a potential association of 8‐iso‐prostaglandin F2α (8‐
iso‐PGF2α) levels, a biomarker of lipid peroxidation, with dementia are limited. Methods …